Until now, several drugs, such as hormone replacement therapy, bisphosphonates, RANKL inhibitors, and teriparatide, have been developed to treat osteoporosis via preventing OC-mediated bone resorption [31–34]. This evidence concerns the gene TNFSF11 and osteoporosis.